SCHEDULE: Millennium Management Discloses 5.4% Stake in RxSight

Millennium Management LLC and its affiliates have reported a 5.4% beneficial ownership stake in RxSight, Inc., holding 2,193,062 shares of common stock.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander collectively reported beneficial ownership of 2,193,062 shares of RxSight, Inc. common stock.
• This ownership represents 5.4% of RxSight, Inc.'s outstanding common stock.
• The reporting persons hold shared voting power and shared dispositive power over all 2,193,062 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous ownership disclosure.
• The securities were acquired and are held for investment purposes, with a certification that they are not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or prospects.

Positives

• Significant institutional investment by Millennium Management, a prominent hedge fund, which may be perceived as a vote of confidence in RxSight, Inc.

Future Outlook

No forward-looking statements or guidance from RxSight, Inc. are provided in this beneficial ownership filing.

Industry Context

This filing indicates a significant institutional investor's position in RxSight, Inc., a company operating in the medical device sector, specifically ophthalmology. Such disclosures are common and reflect ongoing portfolio adjustments by large investment firms.

Stakeholder Impact

• Shareholders: Increased institutional ownership may lead to greater market visibility and potentially influence trading volume or share price.
• Company Management: Awareness of a significant institutional holder in the company's stock.

Key Dates

Keywords

RxSight, Millennium Management, Israel A. Englander, Common Stock, Beneficial Ownership, Schedule 13G, Institutional Investor, Equity Stake